Please Download Flash

Stephen Knight, M.D.
Robert Weisskoff, Ph.D.
Richard W. Fedorowich Jr.
Ben Auspitz
Thomas R. Beck, M.D.
Declan Doogan, M.D.
Hingge Hsu, M.D.
Melissa Packard
Jim Case
Wei Li, Ph.D.
Ketan Patel, M.D.
Eric Golding, M.D.
Rushika Fernandopulle, M.D.
1 Main Street, 13th Floor
Cambridge, MA 02142

 phone: +1 617 231 2400
 fax: +1 617 231 2425
Thomas R. Beck, M.D.
Venture Partner
Tom joined Fidelity Biosciences in September, 2007. Most recently, he served as President, Chief Operating Officer at Dyax Corp. Prior to that, he held positions at UCB Pharma (Corporate Vice President, Director of Global Research and Development), CytoMed, Inc (Chairman and Chief Executive Officer), and Enzytech, Inc (President). He began his industry career at Smith Kline and French, where he held positions in both clinical development and business development.

Dr. Beck is Board-certified in Internal Medicine and Nephrology and was Assistant Professor of Medicine at Temple University School of Medicine prior to joining the pharmaceutical industry. He received his B.S. degree from Yale University and his M.D. from Cornell University.

Dr. Beck currently serves on the Board of Directors of Mersana Therapeutics and Vicept Therapeutics.